It is an awkward fact that effective public health control of schistosomiasis in Africa has yet to deliver a fully comprehensive intervention for appropriate anthelmintic treatment of those preschool-age children and infants with active infection(s) and/or insidious disease. Over the last decade, despite the steady progress of the Pediatric Praziquantel Consortium in developing a monoenantiomeric oral dispersible tablet, future challenges remain in securing its deployment and implementation at scale. This commentary provides a forward-looking critique for the international community, reminding us of this unfortunate treatment gap, and seeks to encourage commensurate action on ameliorating this overlooked medical inequity.
BT - International Health DO - 10.1093/inthealth/ihae094 LA - ENG M3 - Article N2 -It is an awkward fact that effective public health control of schistosomiasis in Africa has yet to deliver a fully comprehensive intervention for appropriate anthelmintic treatment of those preschool-age children and infants with active infection(s) and/or insidious disease. Over the last decade, despite the steady progress of the Pediatric Praziquantel Consortium in developing a monoenantiomeric oral dispersible tablet, future challenges remain in securing its deployment and implementation at scale. This commentary provides a forward-looking critique for the international community, reminding us of this unfortunate treatment gap, and seeks to encourage commensurate action on ameliorating this overlooked medical inequity.
PB - Oxford University Press (OUP) PY - 2025 EP - 3 T2 - International Health TI - Schistosomiasis treatment in young children: a welcome step towards deployment of the paediatric praziquantel formulation UR - https://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihae094/61616811/ihae094.pdf SN - 1876-3413, 1876-3405 ER -